title: Editorial Commentary: Colistin and a New Paradigm in Drug Development.
authors.affiliation: Pharmacologie cellulaire et moléculaire and Centre of Clinical Pharmacy, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium.
authors.forename: Françoise
authors.initials: F
authors.lastname: Van Bambeke
authors.affiliation: Pharmacologie cellulaire et moléculaire and Centre of Clinical Pharmacy, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium.
authors.forename: Paul M
authors.initials: PM
authors.lastname: Tulkens
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003091:Colistin; D024901:Drug Resistance, Multiple, Bacterial / Q000187:drug effects*; D006801:Humans; D008826:Microbial Sensitivity Tests
chemical_list: D000900:Anti-Bacterial Agents; D003091:Colistin
keywords: EMA; FDA; breakpoints; colistin; dosage recommendations